Skip to main content Accessibility help
×
Home

Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)

  • Istvan Bitter (a1), Pal Czobor (a2) (a3) (a4), Martin Dossenbach (a5) and Jan Volavka (a2) (a3)

Abstract

Objective

Antipsychotic medications may reduce hostile and aggressive behavior in schizophrenia. This study compared the effectiveness of antipsychotics in the treatment of aggression.

Method

The Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study compares the effectiveness of antipsychotic treatments in practice setting. Schizophrenia outpatients who initiated or changed to a new antipsychotic are followed in this non-interventional, prospective observational study for up to 3 years, with 6-months data now available on the entire cohort (N = 7655). The presence or absence of verbal or physical hostility/aggression was assessed retrospectively for the period of 6 months before enrollment, and prospectively in the period of 6 months after enrollment (the study treatment period). At baseline, patients in five monotherapy treatment groups (combined N = 3135) were prescribed one of the treatments: clozapine, olanzapine, quetiapine, risperidone, or haloperidol, and had complete data.

Results

Hostile/aggressive behavior was reduced during the treatment period. Olanzapine and risperidone were significantly superior to haloperidol and to clozapine in this respect. These results remained essentially unchanged when adjusting for baseline imbalances in age, gender, age of onset, and substance abuse.

Conclusions

As monotherapy, both olanzapine and risperidone were superior to haloperidol and clozapine in reducing aggression. The relative lack of effectiveness of clozapine may be specific to this study population.

Copyright

Corresponding author

*Corresponding author. Tel./fax: +36 1 303 6244. E-mail address:bitter@psych.sote.hu (I. Bitter).

References

Hide All
[1]Bitter, I., Basson, B.R., Dossenbach, M.R.Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int. Clin. Psychopharmacol., 2005; 20: 11921
[2]Buckley, P., Bartell, J., Donenwirth, K., Lee, S., Torigoe, F., Schulz, S.C.Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull. Am. Acad. Psychiatry Law 1995; 23: 607611
[3]Chengappa, K.N., Goldstein, J.M., Greenwood, M., John, V., Levine, J.A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin. Ther., 2003; 25: 2530541
[4]Chiles, J.A., Davidson, P., McBride, D.Effects of clozapine on use of seclusion and restraint at a state hospital. Hosp. Community Psychiatry 1994; 45: 269271
[5]Citrome, L., Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J.-P., McEvoy, J., et al.Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility in treatment-resistant patients with schizophrenia and schizoaffective disorder. Psychiatr. Serv. 2001; 52: 15101514
[6]Czobor, P., Volavka, J., Meibach, R.C.Effect of risperidone on hostility in schizophrenia. J. Clin. Psychopharmacol. 1995; 15: 243249
[7]Dossenbach, M., Erol, A., el Mahfoud, K.M., Shaheen, M.O., Sunbol, M.M., Boland, J., et al.Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. J. Clin. Psychiatry, 2004; 65: 3312321
[8]Ebrahim, G.M., Gibler, B., Gacono, C.B., Hayes, G.Patient response to clozapine in a forensic psychiatric hospital. Hosp. Community Psychiatry 1994; 45: 271273
[9]Guy, W.ECDEU Assessment Manual for Psychopharmacology Rockville: National Institute of Mental Health; 1976
[10]Haro, J.M., Kamath, S.A., Ochoa, S., Novick, D., Rele, K., Fargas, A., et al.The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta. Psychiatr. Scand. 416Suppl2003 1623
[11]Kinon, B.J., Roychowdhury, S.M., Milton, D.R., Hill, A.L.Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia. J. Clin. Psychiatry 62Suppl 22001 1721
[12]Korb, F.A., Trzebiatowska, I., Janikova, E., Winkler-Skaza, V., Ilies, D., Peciukaitiene, D., et al.The Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study: Baseline clinical and functional characteristics and antipsychotic use of patterns in the Central and Eastern Europe (CEE) region. Psychiatria Danubina 2003; 15: 163174
[13]Korb, F.A., Yenilmez, C., Belaid, A., Ghazi, M., Omar, A.-E., Bitter, I.The intercontinental schizophrenia outpatient health outcomes (ic-soho) study: baseline clinical and functional characteristics and antipsychotic use patterns in the North Africa and Middle Eastern (amea) region. South African Psychiatry Review 2004; 7: 2734
[14]Maier, G.J.The impact of clozapine on 25 forensic patients. Bull. Am. Acad. Psychiatry Law 1992; 20: 297307
[15]Mallya, A.R., Roos, P.D., Roebuck-Colgan, K.Restraint, seclusion, and clozapine. J. Clin. Psychiatry 1992; 53: 395397
[16]Ratey, J.J., Leveroni, C., Kilmer, D., Gutheil, C., Swartz, B.The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. J. Clin. Psychiatry 1993; 54: 219223
[17]Spivak, B., Roitman, S., Vered, Y., Mester, R., Graff, E., Talmon, Y., et al.Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin. Neuropharmacol., 1998; 21: 4245250
[18]Swanson, J.W., Swartz, M.S., Elbogen, E.B., Van Dorn, R.A.Reducing violence risk in persons with schizophrenia: olanzapine versus risperidone. J. Clin. Psychiatry, 2004; 65: 1216661673
[19]Treuer, T., Dossenbach, M., Meder, J., Herman, E., Pecenak, J., Tavar, R., et al.Observational study of schizophrenia outpatients in Central and Eastern Europe: 3- and 6-month efficacy and safety results. Socialna Psihijatria 2004; 32: 4957
[20]Volavka, J.Neurobiology of Violence. 2 edWashington, DC: American Psychiatric Publishing, Inc.; 2002
[21]Volavka, J., Laska, E., Baker, S., Meisner, M., Czobor, P., Krivelevich, I.History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on determinants of outcome of severe mental disorders. Br. J. Psychiatry 1997; 171: 914
[22]Volavka, J., Zito, J.M., Vitrai, J., Czobor, P.Clozapine effects on hostility and aggression in schizophrenia. J. Clin. Psychopharmacol. 1993; 13: 287289
[23]Wilson, W.H., Claussen, A.M.18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatr. Serv. 1995; 46: 386389

Keywords

Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)

  • Istvan Bitter (a1), Pal Czobor (a2) (a3) (a4), Martin Dossenbach (a5) and Jan Volavka (a2) (a3)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)

  • Istvan Bitter (a1), Pal Czobor (a2) (a3) (a4), Martin Dossenbach (a5) and Jan Volavka (a2) (a3)
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *